Panel Discussion: Indian Regulatory Landscape

Time: 10:30 – 11:45 Hrs


Panel would discuss the following:

  • Is there a role for lower cost innovation from Asia/ India?
  • Presentation on evolving pathways and Industry’s expectations from the Indian Regulatory
  • Key development in the Indian regulatory landscape in the last few months
  • To simplify Clinical trial approval process at the center without compromising the review process
  • Various on the process of the trials being done in India. Are these unique requirements in Indian Regulatory system isolating India?

Chairperson:

Mr. Apurva Shah, Founder and Group Managing Director, Veeda Clinical Research Pvt. Ltd., India


Panelists:

  • Mr. Solomon Yimam, Assistant Country Director, U.S. FDA India Office, India
  • Dr. Khalid Khan, Managing Director, Fermish Clinical Technologies Pvt. Ltd., India
  • Ms. Maggie Massam, Head of Business Development, Clinical Practices Resource Datalink (CPRD), MHRA, UK
  • Ms. Divya Chadha Manek, NIHR Clinical Research Network, UK
 

Global Leaders @BioAsia 2015

Conferences





Subscribe to email updates

Information about current events related to BioAsia 2015

For More Info Contact -

Ms. Paridhi Gupta
paridhi@bioasia.in

+91 - 40 - 6644 6477 / 6577

Organizers Supported By

Knowledge Partner

Event Partner